1. Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study
- Author
-
Arianna Dal Buono, Rossella Meli, Federica Lubrano Lobianco, Nicola Pugliese, Massimo Zuin, Alessio Aghemo, Pier Maria Battezzati, Adriano De Santis, Daniela Maggi, Alessia Giorgini, Clara Dibenedetto, Ana Lleo, Antonio Capogreco, and S. Monico
- Subjects
Liver Cirrhosis ,Male ,medicine.medical_specialty ,Genotype ,Sustained Virologic Response ,Hepacivirus ,030204 cardiovascular system & hematology ,elderly ,Antiviral Agents ,HCV Positive ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Chronic hepatitis ,Internal medicine ,antiviral therapy ,80 and over ,medicine ,Humans ,Drug Interactions ,Pharmacology (medical) ,tolerability ,hepatitis c ,Retrospective Studies ,Aged, 80 and over ,drug interaction ,business.industry ,Antiviral therapy ,food and beverages ,General Medicine ,Hepatitis C, Chronic ,Drug interaction ,chronic ,aged ,Tolerability ,030220 oncology & carcinogenesis ,Virologic response ,HCV ,aged, 80 and over ,antiviral agents ,cohort studies ,drug interactions ,female ,follow-up studies ,genotype ,hepacivirus ,humans ,liver cirrhosis ,male ,retrospective studies ,sustained virologic response ,Female ,Life study ,business ,Follow-Up Studies - Abstract
Background: Treatment of chronic Hepatitis C with directly acting antivirals (DAAs) can bring to sustained virologic response (SVR) in approximately 95% of patients. Efficacy and safety of DAAs in ...
- Published
- 2021
- Full Text
- View/download PDF